João Marcelo Lopes Toscano de Brito
João Marcelo Lopes Toscano de Brito has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Alessandro Wasum Mariani
University of Sao Paulo, Sao Paulo, SP, Brazil
2 shared publications - 4 Fernanda Kaori Fujiki3
Rede D’Or, São Paulo (SP), Brasil. 4. Instituto do Câncer do Estado de São Paulo, São Paulo (SP), Brasil
1 shared publication - Adelino Ferreira Leite-Moreira
University of Porto
1 shared publication - Ana Pérez González
Department of Digestive Endoscopy, Hospital Universitario Puerta de Hierro Majadahonda, 28222 Madrid, Spain
1 shared publication - António Pinto da Costa
Department of Digestive Endoscopy, Hospital Universitario Puerta de Hierro Majadahonda, 28222 Madrid, Spain
1 shared publication - Belén Agudo Castillo
Gastroenterology and Hepatology, Puerta de Hierro University Hospital of Majadahonda, Majadahonda, Spain
1 shared publication
Latest Publications
- Open Access
- 8 July 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (14) , 5356
Artificial Intelligence and Endobronchial Ultrasound for Lymph-Node Detection and Characterization: A Pioneer Multicenter Transatlantic Study
Background/Objectives: Accurate mediastinal and hilar lymph node (LN) assessment is central to lung cancer staging and treatment selection. Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) has become the standard minimally invasive procedure for mediastinal staging, enabling real-time identification, characterization and sampling of LNs. Although effective, this technique remains operator dependent, and subject to interobserver variability. This study aims to report the development of a Vision Transformer-based AI model for automatic LN detection and classification on EBUS images. Methods: A multicenter, multidevice, retrospective study, using EBUS images of three referral centers (Spain and Brazil). The dataset included images of patients with benign and malignant LNs. Bounding-box annotations were applied for LN localization, and LNs were classified as benign or malignant according to histopathologic reference standards. Detection performance was evaluated with mean average precision, at an intersection over union threshold of 0.5 (mAP50). Characterization performance was assessed using accuracy, sensitivity, specificity, and area under the receiver operating characteristic curve (AUROC). Results: The dataset included 6492 images from 27 patients, of whom 16 had malignant LNs. In the test set, the model achieved a mAP50 of 0.79 for LN detection. For malignant characterization, the model achieved an accuracy of 90.6%, sensitivity of 85.4%, and an AUROC of 0.938. Conclusions: The results of this study support the feasibility of AI-assisted EBUS interpretation for nodal staging workflows and raise the possibility that AI-assisted EBUS could enhance diagnostic performance, while reducing operator variability. Larger prospective studies are needed before clinical implementation.
- 8 July 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (14) , 5356
Open AccessArtificial Intelligence and Endobronchial Ultrasound for Lymph-Node Detection and Characterization: A Pioneer Multicenter Transatlantic Study
Background/Objectives: Accurate mediastinal and hilar lymph node (LN) assessment is central to lung cancer staging and treatment selection. Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) has become the standard minimally invasive procedure for mediastinal staging, enabling real-time identification, characterization and sampling of LNs. Although effective, this technique remains operator dependent, and subject to interobserver variability. This study aims to report the development of a Vision Transformer-based AI model for automatic LN detection and classification on EBUS images. Methods: A multicenter, multidevice, retrospective study, using EBUS images of three referral centers (Spain and Brazil). The dataset included images of patients with benign and malignant LNs. Bounding-box annotations were applied for LN localization, and LNs were classified as benign or malignant according to histopathologic reference standards. Detection performance was evaluated with mean average precision, at an intersection over union threshold of 0.5 (mAP50). Characterization performance was assessed using accuracy, sensitivity, specificity, and area under the receiver operating characteristic curve (AUROC). Results: The dataset included 6492 images from 27 patients, of whom 16 had malignant LNs. In the test set, the model achieved a mAP50 of 0.79 for LN detection. For malignant characterization, the model achieved an accuracy of 90.6%, sensitivity of 85.4%, and an AUROC of 0.938. Conclusions: The results of this study support the feasibility of AI-assisted EBUS interpretation for nodal staging workflows and raise the possibility that AI-assisted EBUS could enhance diagnostic performance, while reducing operator variability. Larger prospective studies are needed before clinical implementation.
- Open Access
- 30 June 2025
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 51 (3) , e20250236
The staging evolution dilemma: TNM-9 sharpens anatomical precision, but is biology still offstage?
- 30 June 2025
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 51 (3) , e20250236
Open AccessThe staging evolution dilemma: TNM-9 sharpens anatomical precision, but is biology still offstage?
- Open Access
- 1 April 2025
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 17 (4) , 2091-2100
The use of postoperative X-ray to evaluate residual pleural space and predict infectious pleuropulmonary complications after lung resection for infectious disease
Background: Postoperative residual pleural space (RPS) is a critical point in the evaluation of patients undergoing pulmonary resection by infectious pulmonary diseases. This study aims to correlate its incidence, and size, with the risk to develop infectious pleuropulmonary complications. Methods: Retrospective cohort of patients undergoing non-pneumonectomy resection due to infectious lung disease. Two thoracic surgeons analyzed the radiographs systematically. The assessment consisted of defining the presence of a postoperative RPS, and its area calculation the ratio between the area of the complete pleural cavity. These measures were used to predict the risk for infectious pleuropulmonary complications in the first 30 postoperative days. Results: From the total of 135 patients 37.7% had tuberculosis. On the 4th postoperative chest X-ray, 76 (58%) presented RPS. Those patients had an increased risk [risk ratio (RR) =1.47; 95% confidence interval (CI): 1.12–1.92; P=0.01] to develop infectious pleuropulmonary complications. For empyema only the risk was 3.68 (95% CI: 1.12–12.11; P=0.01). In the subgroup with a cavity ratio ≥20%, it was greater: 6.2 (95% CI: 2.7–14.4; P=0.001) for empyema, 2.24 (95% CI: 1.3–4.9; P=0.043) for pneumonia. The multivariate analysis showed a hazard ratio of 6.24 (95% CI: 1.95–19.93; P=0.002) for the development of empyema. Conclusions: This study demonstrates the applicability of a simple and accessible methodology in the measurement of postoperative RPS. Their results proved its relation to a greater chance of developing infectious pleuropulmonary complications.
- 1 April 2025
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 17 (4) , 2091-2100
Open AccessThe use of postoperative X-ray to evaluate residual pleural space and predict infectious pleuropulmonary complications after lung resection for infectious disease
Background: Postoperative residual pleural space (RPS) is a critical point in the evaluation of patients undergoing pulmonary resection by infectious pulmonary diseases. This study aims to correlate its incidence, and size, with the risk to develop infectious pleuropulmonary complications. Methods: Retrospective cohort of patients undergoing non-pneumonectomy resection due to infectious lung disease. Two thoracic surgeons analyzed the radiographs systematically. The assessment consisted of defining the presence of a postoperative RPS, and its area calculation the ratio between the area of the complete pleural cavity. These measures were used to predict the risk for infectious pleuropulmonary complications in the first 30 postoperative days. Results: From the total of 135 patients 37.7% had tuberculosis. On the 4th postoperative chest X-ray, 76 (58%) presented RPS. Those patients had an increased risk [risk ratio (RR) =1.47; 95% confidence interval (CI): 1.12–1.92; P=0.01] to develop infectious pleuropulmonary complications. For empyema only the risk was 3.68 (95% CI: 1.12–12.11; P=0.01). In the subgroup with a cavity ratio ≥20%, it was greater: 6.2 (95% CI: 2.7–14.4; P=0.001) for empyema, 2.24 (95% CI: 1.3–4.9; P=0.043) for pneumonia. The multivariate analysis showed a hazard ratio of 6.24 (95% CI: 1.95–19.93; P=0.002) for the development of empyema. Conclusions: This study demonstrates the applicability of a simple and accessible methodology in the measurement of postoperative RPS. Their results proved its relation to a greater chance of developing infectious pleuropulmonary complications.
- Open Access
- 31 October 2021
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 47 (5) , e20210224
Lung autotransplantation for the treatment of locally advanced tumors
- 31 October 2021
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 47 (5) , e20210224
Open AccessLung autotransplantation for the treatment of locally advanced tumors
- Open Access
- 14 April 2021
- Published by SAGE Publications in Asian Cardiovascular and Thoracic Annals
- Vol. 29 (6) , 541-548
Pneumomediastinum in COVID-19 disease: Outcomes and relation to the Macklin effect
Aim: Pneumomediastinum (PM) is associated with several etiologies and mechanisms. Although it has been described more than 100 years ago, the literature is limited to small retrospective studies. This study aimed to follow patients with coronavirus disease (COVID-19) that developed PM during hospitalization and describe their clinical and radiological evolution. Methods: A prospective cohort was developed with patients with PM, excluding those with aerodigestive trauma, inside a hospital COVID-19 dedicated hospital. Clinical variables including onset of symptoms, hemodynamic instability, associated complications, the need of interventions, and disease course were all recorded. Also, radiological findings such as the presence of the Macklin effect, extension of lung involvement by COVID-19, and characteristics of the PM were analyzed. Results: Twenty-one patients with non-traumatic PM were followed, resulting in an overall incidence of 0.5% during the study period. Seven (33%) patients had associated pneumothorax and malignant/tension PM was observed in three (14%) cases. The Macklin effect could be found in 11 patients (52%) and the majority of them had more than 50% of lung involvement due to COVID-19. The mortality rate was 49%; however, no deaths were directly related to the PM. Conclusions: PM incidence is probably increased in the severe acute respiratory syndrome caused by COVID-19, especially in those with greater involvement of the lungs, and the Macklin effect may be an important underlying mechanism of this complication. Usually, PM has a benign course, but complications like tension/malignant PM may occur requiring prompt detection and intervention.
- 14 April 2021
- Published by SAGE Publications in Asian Cardiovascular and Thoracic Annals
- Vol. 29 (6) , 541-548
Open AccessPneumomediastinum in COVID-19 disease: Outcomes and relation to the Macklin effect
Aim: Pneumomediastinum (PM) is associated with several etiologies and mechanisms. Although it has been described more than 100 years ago, the literature is limited to small retrospective studies. This study aimed to follow patients with coronavirus disease (COVID-19) that developed PM during hospitalization and describe their clinical and radiological evolution. Methods: A prospective cohort was developed with patients with PM, excluding those with aerodigestive trauma, inside a hospital COVID-19 dedicated hospital. Clinical variables including onset of symptoms, hemodynamic instability, associated complications, the need of interventions, and disease course were all recorded. Also, radiological findings such as the presence of the Macklin effect, extension of lung involvement by COVID-19, and characteristics of the PM were analyzed. Results: Twenty-one patients with non-traumatic PM were followed, resulting in an overall incidence of 0.5% during the study period. Seven (33%) patients had associated pneumothorax and malignant/tension PM was observed in three (14%) cases. The Macklin effect could be found in 11 patients (52%) and the majority of them had more than 50% of lung involvement due to COVID-19. The mortality rate was 49%; however, no deaths were directly related to the PM. Conclusions: PM incidence is probably increased in the severe acute respiratory syndrome caused by COVID-19, especially in those with greater involvement of the lungs, and the Macklin effect may be an important underlying mechanism of this complication. Usually, PM has a benign course, but complications like tension/malignant PM may occur requiring prompt detection and intervention.